John J Dillon MD MS
Associate Professor, Internal Medicine, Mayo Medical School
Join to View Full Profile
200 1st St SWRochester, MN 55905
Phone+1 507-284-2511
Dr. Dillon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- John Dillon, MD is a nephrologist based in Rochester, MN. He completed his Residency in Internal Medicine and a subsequent Fellowship in Nephrology at the University of North Carolina Hospitals. He graduated from Columbia University's Vagelos College of Physicians and Surgeons in 1983. With expertise in general nephrology, acute renal failure, chronic kidney disease, glomerular disease, and anti-glomerular basement membrane disease, Dr. Dillon has authored multiple publications on topics such as SARS-CoV-2 vaccination in dialysis patients and the use of machine learning in renal care. He has also been involved in clinical trials, including trials of rituximab for various forms of nephropathy.
Education & Training
University of North Carolina HospitalsFellowship, Nephrology, 1986 - 1989- University of North Carolina HospitalsResidency, Internal Medicine, 1983 - 1986
Columbia University Vagelos College of Physicians and SurgeonsClass of 1983
Certifications & Licensure
MN State Medical License 2002 - 2026
IL State Medical License 1994 - 2002
NC State Medical License 1986 - 1998
OH State Medical License 1990 - 1996
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Nephrology
Clinical Trials
- Pilot Study of Rituximab for Membranoproliferative Glomerulonephritis Start of enrollment: 2005 Nov 01
- Rituximab in Progressive Immunoglobulin A (IgA) Nephropathy Start of enrollment: 2009 Feb 01
- MEmbranous Nephropathy Trial Of Rituximab Start of enrollment: 2011 Nov 01
Publications & Presentations
PubMed
- 2 citationsMortality Risk Stratification Utilizing Artificial Intelligence Electrocardiogram for Hyperkalemia in Cardiac Intensive Care Unit Patients.David M Harmon, Chris K Heinrich, John J Dillon, Rickey E Carter, Kianoush B Kashani
JACC. Advances. 2024-09-01 - Validation of Noninvasive Detection of Hyperkalemia by Artificial Intelligence-Enhanced Electrocardiography in High Acuity Settings.David M Harmon, Kan Liu, Jennifer Dugan, Jacob C Jentzer, Zachi I Attia
Clinical Journal of the American Society of Nephrology. 2024-08-01 - Validation of Non-invasive Detection of Hyperkalemia by Artificial Intelligence Enhanced Electrocardiography in High Acuity Settings.David M Harmon, Kan Liu, Jennifer Dugan, Jacob C Jentzer, Zachi I Attia
Clinical Journal of the American Society of Nephrology. 2024-06-21
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
